Research at NCI-Frederick
Scientists at NCI-Frederick, part of the National Institutes of Health
(NIH), direct research into the causes, treatment, and prevention of
cancer, AIDS, and related diseases. From basic research into the molecular
mechanisms of carcinogenesis to pre-clinical investigation of potential
new treatments, scientists at NCI-Frederick are studying the origins
of cancer—the genes, proteins, and signals involved in initiation—and
identifying possible targets to treat or prevent the disease. In addition
to the many NCI labs located here, the Frederick campus also serves as
a major biotechnology resource center for NCI/NIH. The Advanced
Technology Program is developing new technologies in areas such as
proteomics and imaging, while the Advanced
Biomedical Computing Center provides fully integrated, high performance,
scientific computing support. Visit the links below to learn more.
Scientists – A comprehensive
index of senior scientists working at NCI-Frederick.
Labs/Branches/Programs – An
index of all NCI/NIH scientific programs and groups located on the Frederick
campus.
Biotechnology Resources – Information
on the NCI/SAIC Research Technology Program and other core resources.
Faculties & Interest
Groups – A directory of NCI’s intramural research faculties
as well as various NCI/NIH scientific interest groups.
Center for Cancer Research (CCR) – The
CCR is the largest research component of NCI’s Intramural Program.
Many of Center’s research laboratories and programs are located
on the Frederick campus.
Developmental Therapeutics Program
(DTP) – The DTP is the NCI’s drug discovery and development
arm. The Developmental Therapeutics Program plans, conducts, and facilitates
the development of new therapeutic agents for cancer and AIDS. DTP
is a major research resource; the Program provides Web-accessible data
and tools, vialed and plated compounds, tumor cells, animals, and Investigational
New Drug (IND)-directed studies.
|